No Data
No Data
No Data
No Data
No Data
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating
GlobeNewswireApr 16 16:05 ET
Express News | Turnstone Biologics Appoints William Waddill to Its Board of Directors
Moomoo 24/7Apr 16 09:00 ET
10 Buy-Rated Stocks With Latest Insider Purchases
Yahoo FinanceApr 14 12:52 ET
Express News | Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Moomoo 24/7Apr 11 07:17 ET
Buy Rating on Annexon Biosciences: Promising Pipeline and Strategic Growth Potential
TipRanksApr 11 06:35 ET
Annexon(ANNX.US) Director Buys US$19,411.2 in Common Stock
$Annexon(ANNX.US)$ Director Carson William H. purchased 3,200 shares of common stock on Apr 8, 2024 at an average price of $6.066 for a total value of $19,411.2.Source: Announcement What is statement
moomoo NewsApr 10 19:57 ET
No Data
No Data